Marleen Renard
- Molecular Biology
- Oncology top 10%
- Neurology top 5%
- Pathology and Forensic Medicine top 5%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Anne UyttebroeckJavier GánameBart BijnensBénédicte EyskensLuc MertensPiet ClausGeorge R. SutherlandJan D’hooge
- Topics
- Childhood Cancer Survivors' Quality of Life (8 papers)Acute Lymphoblastic Leukemia research (7 papers)Neuroblastoma Research and Treatments (6 papers)
- Journals
- BloodNeurologyThe Lancet Neurology
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
Marleen Renard
48 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 347
- Oncology 333
- Neurology 306
- Pathology and Forensic Medicine 279
- Cardiology and Cardiovascular Medicine 263
Countries citing papers authored by Marleen Renard
This map shows the geographic impact of Marleen Renard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marleen Renard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marleen Renard more than expected).
Fields of papers citing papers by Marleen Renard
This network shows the impact of papers produced by Marleen Renard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marleen Renard. The network helps show where Marleen Renard may publish in the future.
Co-authorship network of co-authors of Marleen Renard
This figure shows the co-authorship network connecting the top 25 collaborators of Marleen Renard. A scholar is included among the top collaborators of Marleen Renard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marleen Renard. Marleen Renard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 14 | |
| 6 | 81 | |
| 7 | 39 | |
| 8 | 9 | |
| 9 | 18 | |
| 10 | 15 | |
| 11 | 3 | |
| 12 | Is the mortality benefit of primary PCI over thrombolysis also present in diabetic STEMI patients? A population study of STEMI patients | 1 |
| 13 | 63 | |
| 14 | 150 | |
| 15 | 113 | |
| 16 | 29 | |
| 17 | 12 | |
| 18 | 31 | |
| 19 | 26 | |
| 20 | 8 |
About Marleen Renard
Marleen Renard is a scholar working on Neurology, Pediatrics, Perinatology and Child Health and Rheumatology, having authored 50 papers that have together received 1.5k indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Neuroblastoma Research and Treatments (6 papers). The work is most often cited by research in Neurology (306 citations), Pathology and Forensic Medicine (279 citations) and Cancer Research (232 citations). Marleen Renard has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Anne Uyttebroeck, Javier Gáname, Bart Bijnens, Bénédicte Eyskens, Luc Mertens, Piet Claus, George R. Sutherland, Jan D’hooge, Raf Sciot and Geneviève Laureys. Their work appears in journals such as Blood, Neurology and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.